The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
- PMID: 10333939
- DOI: 10.2337/diacare.22.2.233
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
Abstract
Objective: To assess the relationship between nondiabetic glucose levels and cardio vascular risk.
Research design and methods: Three independent searches using MEDLINE (1966-1996), followed by a manual search of the references from each retrieved article, were conducted by two physicians and one medical librarian. Data had to be reported in at least three quantiles or intervals so that the nature of the relationship between glucose and cardiovascular events (i.e., linear or nonlinear) could be explored, and to ensure that any incremental cardiovascular risk was consistent across quantiles or intervals.
Results: Analyzed studies comprised 95,783 people (94% male) who had 3,707 cardiovascular events over 12.4 years (1,193,231 person-years). Studies reporting fasting glucose levels (n = 6), 2-h glucose levels (n = 7), 1-h glucose levels (n = 5), and casual glucose levels (n = 4) were included. The glucose load used varied from 50 to 100 g. The highest glucose interval for most studies included glucose values in the diabetic range. The relationship between glucose levels and the risk of a cardiovascular event was modeled for each study and the beta-coefficients were combined. Compared with a glucose level of 4.2 mmol/l (75 mg/dl), a fasting and 2-h glucose level of 6.1 mmol/dl (110 mg/dl) and 7.8 mmol/l (140 mg/dl) was associated with a relative cardiovascular event risk of 1.33 (95% CI 1.06-1.67) and 1.58 (95% CI 1.19-2.10), respectively.
Conclusions: The progressive relationship between glucose levels and cardiovascular risk extends below the diabetic threshold.
Comment in
- ACP J Club. 1999 Jul-Aug;131(1):23
-
Fasting blood glucose and risk of cardiovascular disease.Diabetes Care. 1999 Aug;22(8):1385-7. doi: 10.2337/diacare.22.8.1385. Diabetes Care. 1999. PMID: 10480797 Clinical Trial. No abstract available.
Similar articles
-
Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.Eur J Prev Cardiol. 2012 Aug;19(4):755-64. doi: 10.1177/1741826711409327. Epub 2011 May 6. Eur J Prev Cardiol. 2012. PMID: 21551215
-
Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.Diabetes Res Clin Pract. 2009 Jul;85(1):90-5. doi: 10.1016/j.diabres.2009.04.006. Epub 2009 May 2. Diabetes Res Clin Pract. 2009. PMID: 19414206
-
Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.Diabetes Care. 1998 Dec;21(12):2094-7. doi: 10.2337/diacare.21.12.2094. Diabetes Care. 1998. PMID: 9839099
-
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. doi: 10.1016/j.diabres.2007.05.004. Epub 2007 Jun 29. Diabetes Res Clin Pract. 2007. PMID: 17601626 Review.
-
Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.Acta Med Indones. 2004 Jan-Mar;36(1):36-41. Acta Med Indones. 2004. PMID: 15673935 Review.
Cited by
-
Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors.Clin Cancer Res. 2013 Sep 15;19(18):5158-69. doi: 10.1158/1078-0432.CCR-12-3300. Epub 2013 Jul 5. Clin Cancer Res. 2013. PMID: 23833310 Free PMC article.
-
Inverse association between fasting plasma glucose and risk of ventricular arrhythmias.Diabetologia. 2015 Aug;58(8):1797-802. doi: 10.1007/s00125-015-3646-0. Epub 2015 Jun 3. Diabetologia. 2015. PMID: 26032023
-
Statin Use is Associated With Insulin Resistance in Participants of the Canadian Multicentre Osteoporosis Study.J Endocr Soc. 2020 May 15;4(8):bvaa057. doi: 10.1210/jendso/bvaa057. eCollection 2020 Aug 1. J Endocr Soc. 2020. PMID: 32715271 Free PMC article.
-
Citropten Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via the TRPV1 Receptor.ACS Omega. 2024 Jun 25;9(27):29829-29839. doi: 10.1021/acsomega.4c03539. eCollection 2024 Jul 9. ACS Omega. 2024. PMID: 39005766 Free PMC article.
-
Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial.Medicine (Baltimore). 2016 Oct;95(43):e5229. doi: 10.1097/MD.0000000000005229. Medicine (Baltimore). 2016. PMID: 27787387 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical